Literature DB >> 32405617

Optical coherence tomography use in idiopathic intracranial hypertension.

Kiran Malhotra1, Tanyatuth Padungkiatsagul2,3, Heather E Moss3,4.   

Abstract

Idiopathic intracranial hypertension (IIH) is a condition in which elevated pressure in the cerebrospinal fluid can lead to optic nerve head (ONH) dysfunction and subsequent visual impairment. Physicians are currently limited in their ability to monitor and manage this condition, as clinical symptoms and exam findings are often delayed in response to changes in intracranial pressure. In order to find other biomarkers of disease, researchers are using imaging modalities such as optical coherence tomography (OCT) to observe microscopic changes in the eye in this condition. OCT can create 2-dimensional and 3-dimensional high definition images of the retina of the ONH and has been used to study various conditions such as glaucoma and multiple sclerosis. Numerous studies have used OCT in IIH as well, and they have shown that certain retinal layers and the ONH change in thickness and shape in both the short and long term with intracranial pressure changes. OCT is a promising modality for clinical and scientific evaluation of IIH as it is a noninvasive and practical tool to obtain in depth images. This review will discuss how OCT can be used to assess a patient with IIH, both before and after treatment, along with its limitations and future applications.

Entities:  

Keywords:  Optical coherence tomography (OCT); idiopathic intracranial hypertension (IIH); pseudotumor cerebri

Year:  2020        PMID: 32405617      PMCID: PMC7220123          DOI: 10.21037/aes.2019.12.06

Source DB:  PubMed          Journal:  Ann Eye Sci        ISSN: 2520-4122


  52 in total

Review 1.  Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy.

Authors:  J G Fujimoto; C Pitris; S A Boppart; M E Brezinski
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  OCT and chronic papilledema.

Authors:  Avinoam Ophir; Muge Karatas; Jose A Ramirez; Rivka Inzelberg
Journal:  Ophthalmology       Date:  2005-12       Impact factor: 12.079

3.  Application of optical coherence tomography in glaucoma suspect eyes.

Authors:  Maria Pomorska; Patrycja Krzyżanowska-Berkowska; Marta Misiuk-Hojło; Hanna Zając-Pytrus; Andrzej Grzybowski
Journal:  Clin Exp Optom       Date:  2011-10-10       Impact factor: 2.742

4.  Optical coherence tomography of the optic nerve head detects acute changes in intracranial pressure.

Authors:  Aashish Anand; Anastas Pass; Mian Z Urfy; Rosa Tang; Christian Cajavilca; Eusebia Calvillo; Jose I Suarez; Chethan P Venkatasubba Rao; Eric M Bershad
Journal:  J Clin Neurosci       Date:  2016-02-18       Impact factor: 1.961

5.  Relationship between retinal layer thickness and the visual field in early age-related macular degeneration.

Authors:  Jennifer H Acton; R Theodore Smith; Donald C Hood; Vivienne C Greenstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

6.  The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.

Authors:  Catherine R Sheils; William S Fischer; Rachel A Hollar; Lisa M Blanchard; Steven E Feldon
Journal:  Am J Ophthalmol       Date:  2018-08-04       Impact factor: 5.258

7.  Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.

Authors:  Gema Rebolleda; Francisco J Muñoz-Negrete
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

8.  Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT.

Authors:  Falko Kaufhold; Ella Maria Kadas; Christoph Schmidt; Hagen Kunte; Jan Hoffmann; Hanna Zimmermann; Timm Oberwahrenbrock; Lutz Harms; Konrad Polthier; Alexander U Brandt; Friedemann Paul
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Quantitative Association Between Peripapillary Bruch's Membrane Shape and Intracranial Pressure.

Authors:  Amulya Gampa; Gautam Vangipuram; Zainab Shirazi; Heather E Moss
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

10.  Association Between Peripapillary Bruch's Membrane Shape and Intracranial Pressure: Effect of Image Acquisition Pattern and Image Analysis Method, a Preliminary Study.

Authors:  Kiran Malhotra; Megh D Patel; Zainab Shirazi; Heather E Moss
Journal:  Front Neurol       Date:  2018-12-21       Impact factor: 4.003

View more
  5 in total

1.  Resolution of Papilledema Following Ventriculoperitoneal Shunt or Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus: A Pilot Study.

Authors:  Sukriti Das; Nicola Montemurro; Musannah Ashfaq; Dipankar Ghosh; Asit Chandra Sarker; Akhlaque Hossain Khan; Sharbari Dey; Bipin Chaurasia
Journal:  Medicina (Kaunas)       Date:  2022-02-13       Impact factor: 2.430

2.  Clinical profile and retinal nerve fibre layer thickness of optic disc oedema patients at a tertiary care institute in North India.

Authors:  Gitanjli Sood; Ramanuj Samanta; Devesh Kumawat; Ajai Agrawal; Anupam Singh
Journal:  Ther Adv Ophthalmol       Date:  2022-02-14

3.  Tunable alginate hydrogels as injectable drug delivery vehicles for optic neuropathy.

Authors:  Courtney J Maxwell; Andrew M Soltisz; Wade W Rich; Andrew Choi; Matthew A Reilly; Katelyn E Swindle-Reilly
Journal:  J Biomed Mater Res A       Date:  2022-05-23       Impact factor: 4.854

4.  Noninvasive Estimation of Pulsatile and Static Intracranial Pressure by Optical Coherence Tomography.

Authors:  Henrik Holvin Jacobsen; Øystein Kalsnes Jørstad; Morten C Moe; Goran Petrovski; Are Hugo Pripp; Tiril Sandell; Per Kristian Eide
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

5.  Application of optic neuro-ophthalmology imaging in latent meningeal metastases of lung cancer.

Authors:  Shuai Song; Dong Chang; Hao Li; Chunquan Liu; Hongyang Li; Yong Cui
Journal:  Thorac Cancer       Date:  2021-09-09       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.